Published in Circulation on May 02, 2000
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J (2010) 3.62
Epidemiology of heart failure. Circ Res (2013) 2.84
Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail (2010) 2.35
Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail (2009) 1.83
Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation (2010) 1.64
Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure. J Gerontol A Biol Sci Med Sci (2005) 1.64
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circulation (2015) 1.64
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63
Echocardiography practice, training and accreditation in the intensive care: document for the World Interactive Network Focused on Critical Ultrasound (WINFOCUS). Cardiovasc Ultrasound (2008) 1.55
Classification of acute decompensated heart failure: an automated algorithm compared with a physician reviewer panel: the Atherosclerosis Risk in Communities study. Circ Heart Fail (2013) 1.47
Cardiovascular function and the veteran athlete. Eur J Appl Physiol (2010) 1.40
A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Heart (2003) 1.37
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound (2005) 1.34
Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J (2006) 1.32
Defining diastolic dysfunction. Circulation (2000) 1.32
Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart (2005) 1.29
Current perspectives in diastolic dysfunction and diastolic heart failure. Heart (2006) 1.26
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes. Eur Heart J (2014) 1.25
Clinical assessment of left ventricular diastolic function. Heart (2003) 1.21
Assessment of diastolic function: what the general cardiologist needs to know. Heart (2005) 1.17
The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep (2013) 1.11
Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma. Curr Cardiovasc Risk Rep (2011) 1.10
The heart failure epidemic. Int J Environ Res Public Health (2010) 1.07
Diastolic heart failure in the elderly. Heart Fail Rev (2002) 1.07
Management of diastolic heart failure in older adults. BMJ (2004) 1.07
Use and Limitations of E/e' to Assess Left Ventricular Filling Pressure by Echocardiography. J Cardiovasc Ultrasound (2011) 1.05
Diagnosis of heart failure in primary care. Heart Fail Rev (2006) 1.03
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail (2013) 1.00
Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study. PLoS One (2013) 0.97
The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Fail Rev (2006) 0.96
Decreased cardiac functional reserve in heart failure with preserved systolic function. J Card Fail (2010) 0.95
Heart failure with preserved ejection fraction. Glob Cardiol Sci Pract (2012) 0.94
Depressive symptoms increase risk of rehospitalisation in heart failure patients with preserved systolic function. J Clin Nurs (2009) 0.93
Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol (2015) 0.93
Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. Clin Res Cardiol (2009) 0.91
Diastolic dysfunction: a link between hypertension and heart failure. Drugs Today (Barc) (2008) 0.91
Acoustic radiation force-driven assessment of myocardial elasticity using the displacement ratio rate (DRR) method. Ultrasound Med Biol (2011) 0.90
Office management of patients with diastolic heart failure. CMAJ (2009) 0.88
Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction. Heart (2006) 0.86
Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure. Cardiol Res Pract (2013) 0.86
Towards patient-specific cardiovascular modeling system using the immersed boundary technique. Biomed Eng Online (2011) 0.86
Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review. Heart Fail Rev (2015) 0.84
Congestive heart failure in Indians: how do we improve diagnosis & management? Indian J Med Res (2010) 0.84
Isolated diastolic dysfunction--diagnostic value of tissue Doppler imaging, colour M-mode and N-terminal pro B-type natriuretic peptide. Clin Res Cardiol (2007) 0.84
Congestive heart failure: what can we offer our patients? CMAJ (2001) 0.83
Diastolic dysfunction in volume-overload hypertrophy is associated with abnormal shearing of myolaminar sheets. Am J Physiol Heart Circ Physiol (2005) 0.83
Epidemiology of heart failure with preserved ejection fraction. Heart Fail Clin (2014) 0.83
Heart failure with preserved ejection fraction - unwinding the diagnosis mystique. Am J Cardiovasc Dis (2014) 0.83
Agreement between community echocardiography and hospital echocardiography in patients suspected of having left ventricular systolic dysfunction. Postgrad Med J (2005) 0.83
Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res (2014) 0.83
The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Glob Heart (2013) 0.83
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study. BMC Cardiovasc Disord (2014) 0.82
How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing. Neth Heart J (2016) 0.82
Personalized Computer Simulation of Diastolic Function in Heart Failure. Genomics Proteomics Bioinformatics (2016) 0.82
Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist. J Cardiothorac Surg (2009) 0.82
Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function. J Card Fail (2009) 0.81
Magnetic resonance assessment of left ventricular diastolic dysfunction for detecting cardiac allograft vasculopathy in recipients of heart transplants. Int J Cardiovasc Imaging (2011) 0.80
Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia. J Saudi Heart Assoc (2012) 0.79
Diastolic heart failure. BMJ (2003) 0.79
Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.79
Advances in diastolic heart failure. World J Cardiol (2010) 0.78
Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: an electromechanically detailed biophysical modeling study. Front Physiol (2015) 0.78
Assessment of left ventricular diastolic function by gated single-photon emission tomography: comparison with Doppler echocardiography. Eur J Nucl Med Mol Imaging (2003) 0.78
Longitudinal fractional shortening and its relation to diastolic cardiac function. J Med Ultrason (2001) (2008) 0.77
Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessons. Curr Cardiol Rev (2015) 0.77
Time-Dependent Regional Myocardial Strains in Patients with Heart Failure with a Preserved Ejection Fraction. Biomed Res Int (2016) 0.77
Diagnostic Accuracy of NT-ProBNP for Heart Failure with Sepsis in Patients Younger than 18 Years. PLoS One (2016) 0.77
Regional wall motion abnormality at the lateral wall disturbs correlations between tissue Doppler E/e' ratios and left ventricular diastolic performance parameters measured by invasive methods. J Echocardiogr (2013) 0.77
[Diastolic heart failure: heart failure with preserved ejection fraction]. Z Gerontol Geriatr (2013) 0.77
Usefulness of left ventricular diastolic function assessed by magnetic resonance imaging over invasive coronary flow reserve measurement for detecting cardiac allograft vasculopathy in heart transplant recipients. Int J Cardiovasc Imaging (2012) 0.76
Effect of simulated dives on diastolic function in healthy men. Eur J Appl Physiol (2011) 0.76
Diastolic heart failure: fact or fiction? Heart (2003) 0.76
Are there differences in acute phase inflammation markers regarding the type of heart failure? Heart Int (2011) 0.76
Management of Chronic Heart Failure in Primary Care: What Evidence do we have for Heart Failure with Preserved Systolic Function? Malays Fam Physician (2010) 0.75
Focused cardiac ultrasound is feasible in the general practice setting and alters diagnosis and management of cardiac disease. Echo Res Pract (2016) 0.75
Echocardiographic evaluation of diastolic heart failure. Australas J Ultrasound Med (2015) 0.75
Relation of Red Cell Distribution Width to Left Ventricular End-Diastolic Pressure and Mortality in Patients With and Without Heart Failure. Am J Cardiol (2017) 0.75
Prognosis of Adults With Borderline Left Ventricular Ejection Fraction. JACC Heart Fail (2016) 0.75
Facts and principles learned at the 31st Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2004) 0.75
Left Ventricular Velocity of Propagation: A Useful Non-Invasive Measurement When Assessing Hemodynamic Alterations in Pulmonary Arterial Hypertension. Cardiol Res (2017) 0.75
New Classification for Heart Failure with Mildly Reduced Ejection Fraction: Greater clarity or more confusion? Sultan Qaboos Univ Med J (2017) 0.75
Heart failure with a normal ejection fraction: treatments for a complex syndrome? Curr Treat Options Cardiovasc Med (2012) 0.75
Defining diastolic heart failure. Circulation (2001) 0.75
Acute pulmonary congestion in patients with systolic heart failure versus diastolic heart failure: experience of a heart emergency unit. Neth Heart J (2005) 0.75
Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome. Front Pharmacol (2017) 0.75
Prediction of true circulatory decompensation in chronic heart failure for optimal timing of mechanical circulatory support: non-invasive arterial-ventricular coupling. J Funct Biomater (2012) 0.75
Rationale, design and methodology for Intraventricular Pressure Gradients Study: a novel approach for ventricular filling assessment in normal and falling hearts. J Cardiothorac Surg (2011) 0.75
Stress-induced Worsening of Left Ventricular Diastolic Function as a Marker of Myocardial Ischemia. J Cardiovasc Echogr (2017) 0.75
The pathophysiology of diastolic heart failure. F1000 Biol Rep (2010) 0.75
Cell- and molecular-level mechanisms contributing to diastolic dysfunction in HFpEF. J Appl Physiol (1985) (2015) 0.75
Key role of congestion in natural history of heart failure. Int J Gen Med (2011) 0.75
Facts and principles learned at the 32nd annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2005) 0.75
The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure. Cardiovasc J Afr (2010) 0.75
Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. Am J Cardiol (2014) 0.75
The prognostic value of anemia in patients with diastolic heart failure. Tex Heart Inst J (2009) 0.75
Ergospirometry and Echocardiography in Early Stage of Heart Failure with Preserved Ejection Fraction and in Healthy Individuals. Arq Bras Cardiol (2015) 0.75
Mechanisms and efficacy of LV pre-excitation for patients with heart failure and supra-normal systolic function. Heart Fail Rev (2000) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
The somatic replication of DNA methylation. Cell (1981) 4.42
Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96
The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Cancer: improving early detection and prevention. A community practice randomised trial. BMJ (1992) 3.76
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) Am J Cardiol (1992) 3.66
Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle, Washington, 1987-1994. Epidemiology (1999) 3.57
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92
Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension (2000) 2.76
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol (2001) 2.57
Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol (1999) 2.51
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. Biochim Biophys Acta (1995) 2.47
Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum (1998) 2.45
The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol (2000) 2.28
Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation (1993) 2.27
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet (2003) 2.26
Resurgence of sleeping sickness in Tambura County, Sudan. Am J Trop Med Hyg (1999) 2.24
Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA (1992) 2.22
Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol (1991) 2.19
Natural history of progressive ischemic stroke in a population treated with heparin. Stroke (1990) 2.14
Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation (1997) 2.14
The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study. Am J Med (1999) 2.09
Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med (1992) 2.08
Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA (1994) 2.03
Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol (1987) 2.01
Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J (1995) 2.00
Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol Cell (2001) 1.97
Death rates from coronary disease--progress and a puzzling paradox. N Engl J Med (1998) 1.95
Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatol (2000) 1.94
FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev (1999) 1.94
Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1991) 1.91
Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J Virol (1988) 1.88
Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation (1997) 1.87
Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study. Circulation (1999) 1.87
Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol (1994) 1.86
Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation (1994) 1.85
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis (2001) 1.84
The natural history of borderline isolated systolic hypertension. N Engl J Med (1993) 1.82
Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am J Respir Crit Care Med (2001) 1.81
Defining radiographic osteoarthritis for the whole knee. Osteoarthritis Cartilage (1997) 1.80
Determinants of heart rate variability. J Am Coll Cardiol (1996) 1.79
Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am Heart J (1983) 1.72
Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community. Hypertension (2000) 1.70
Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation (2000) 1.70
Immortalization of precursor cells from the mammalian CNS. Neuron (1988) 1.65
Heritability of left ventricular mass: the Framingham Heart Study. Hypertension (1997) 1.63
Hemostatic state and atrial fibrillation (the Framingham Offspring Study). Am J Cardiol (2001) 1.63
Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation (1995) 1.61
Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension (1995) 1.61
Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (1999) 1.60
Heritability of longitudinal change in lung function. The Framingham study. Am J Respir Crit Care Med (2001) 1.60
Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum (1996) 1.56
Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet (1969) 1.56
Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J (1995) 1.55
Why is left ventricular hypertrophy so predictive of morbidity and mortality? Am J Med Sci (1999) 1.54
Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. Arch Intern Med (1999) 1.53
Cardiovascular risk factors in the elderly. Am J Cardiol (1989) 1.52
Bio-Beads: an efficient strategy for two-dimensional crystallization of membrane proteins. J Struct Biol (1997) 1.52